0001209191-16-103640.txt : 20160301 0001209191-16-103640.hdr.sgml : 20160301 20160301103346 ACCESSION NUMBER: 0001209191-16-103640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160224 FILED AS OF DATE: 20160301 DATE AS OF CHANGE: 20160301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-313-9650 MAIL ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANIDO VICENTE JR CENTRAL INDEX KEY: 0001207633 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 161471613 MAIL ADDRESS: STREET 1: 1621 BAYSIDE DR CITY: CORONA DEL MAR STATE: CA ZIP: 92625 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-24 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001207633 ANIDO VICENTE JR C/O AERIE PHARMACEUTICALS, INC., 2030 MAIN STREET, SUITE 1500 IRVINE CA 92614 1 1 0 0 Chief Executive Officer Common Stock 2016-02-24 4 A 0 25085 0.00 A 75273 D Stock Option (right to buy) 16.69 2016-02-24 4 A 0 150504 0.00 A 2026-02-24 Common Stock 150504 150504 D These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in four equal annual installments on the anniversary of February 24, 2016. This option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, ratably on each of the 48 monthly anniversaries of February 24, 2016. /s/ Richard J. Rubino, Attorney-in-Fact for Vicente Anido, Jr. 2016-02-29